Achieve Life Sciences Statistics
Share Statistics
Achieve Life Sciences has 34.69M
shares outstanding. The number of shares has increased by 1%
in one year.
| Shares Outstanding | 34.69M |
| Shares Change (YoY) | 1% |
| Shares Change (QoQ) | 0.86% |
| Owned by Institutions (%) | 50.95% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 16,677 |
| FTD / Avg. Volume | 8.61% |
Short Selling Information
The latest short interest is 2.5M, so 7.21% of the outstanding
shares have been sold short.
| Short Interest | 2.5M |
| Short % of Shares Out | 7.21% |
| Short % of Float | 9.39% |
| Short Ratio (days to cover) | 11.21 |
Valuation Ratios
The PE ratio is -2.83 and the forward
PE ratio is -4.4.
Achieve Life Sciences's PEG ratio is
0.16.
| PE Ratio | -2.83 |
| Forward PE | -4.4 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 5.4 |
| P/FCF Ratio | -3.79 |
| PEG Ratio | 0.16 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Achieve Life Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46,
with a Debt / Equity ratio of 0.48.
| Current Ratio | 5.46 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | -0.27 |
| Debt / FCF | -0.33 |
| Interest Coverage | 17.92 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,593,080 |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -47.57% in the
last 52 weeks. The beta is 1.5, so Achieve Life Sciences's
price volatility has been higher than the market average.
| Beta | 1.5 |
| 52-Week Price Change | -47.57% |
| 50-Day Moving Average | 2.6 |
| 200-Day Moving Average | 3.83 |
| Relative Strength Index (RSI) | 50.46 |
| Average Volume (20 Days) | 193,658 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.07M |
| Net Income | -39.83M |
| EBITDA | -37.42M |
| EBIT | -42.01M |
| Earnings Per Share (EPS) | -1.24 |
Full Income StatementBalance Sheet
The company has 12.75M in cash and 9.96M in
debt, giving a net cash position of 2.79M.
| Cash & Cash Equivalents | 12.75M |
| Total Debt | 9.96M |
| Net Cash | 2.79M |
| Retained Earnings | -205.58M |
| Total Assets | 38.63M |
| Working Capital | 29.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -29.77M
and capital expenditures 0, giving a free cash flow of -29.77M.
| Operating Cash Flow | -29.77M |
| Capital Expenditures | n/a |
| Free Cash Flow | -29.77M |
| FCF Per Share | -0.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
